114 related articles for article (PubMed ID: 126365)
1. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides.
Yoda S; Sarrif AM; Yoda A
Mol Pharmacol; 1975 Sep; 11(5):647-52. PubMed ID: 126365
[No Abstract] [Full Text] [Related]
2. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
Yoda A; Yoda S
Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
[No Abstract] [Full Text] [Related]
3. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
Yoda A
Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
[No Abstract] [Full Text] [Related]
4. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
Yoda A; Yoda S; Sarrif AM
Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
[No Abstract] [Full Text] [Related]
5. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
Yoda A; Yoda S
Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
[No Abstract] [Full Text] [Related]
6. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
Wilson WE; Sivitz WI; Hanna LT
Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
[No Abstract] [Full Text] [Related]
7. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
Palatini P
Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
[No Abstract] [Full Text] [Related]
8. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. I. Effects on sodium-sensitive phosphorylation and potassium-sensitive dephosphorylation.
Banerjee SP; Wong SM; Khanna VK; Sen AK
Mol Pharmacol; 1972 Jan; 8(1):8-17. PubMed ID: 4258649
[No Abstract] [Full Text] [Related]
9. Evidence for two forms of fluoride-treated sodium- and potassium-dependent adenosine triphosphatase.
Penzotti SC; Titus E
Mol Pharmacol; 1972 Mar; 8(2):149-58. PubMed ID: 4260221
[No Abstract] [Full Text] [Related]
10. Influence of pH on the interaction of cardiotonic steroids with sodium- and potasssium-dependent adenosine triphosphatase.
Yoda A; Yoda S
Mol Pharmacol; 1978 Jul; 14(4):624-32. PubMed ID: 28472
[No Abstract] [Full Text] [Related]
11. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. V. Dissociation rate constants of digitoxin acetates.
Yoda A; Yoda S
Mol Pharmacol; 1975 Sep; 11(5):653-62. PubMed ID: 126366
[No Abstract] [Full Text] [Related]
12. Association and dissociation rate constants of the complexes between various cardiac monoglycosides and Na, K-ATPase.
Yoda A
Ann N Y Acad Sci; 1974; 242(0):598-616. PubMed ID: 4279608
[No Abstract] [Full Text] [Related]
13. Antibiotics as tools for metabolic studies. XVIII. Inhibition of sodium- and potassium-dependent adenosine triphosphatase.
Susa JB; Lardy HA
Mol Pharmacol; 1975 Mar; 11(2):166-73. PubMed ID: 123632
[No Abstract] [Full Text] [Related]
14. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
Banerjee SP; Wong SM; Sen AK
Mol Pharmacol; 1972 Jan; 8(1):18-29. PubMed ID: 4258646
[No Abstract] [Full Text] [Related]
15. [Chemistry, biochemistry and clinical pharmacology of digitalis glycosides. An overview].
Dwenger A
Arzneimittelforschung; 1973 Oct; 23(10):1439-46. PubMed ID: 4273089
[No Abstract] [Full Text] [Related]
16. [Activity and properties of adenosine triphosphatase in erythrocytes and various tissues (brain, liver, kidney, small intestine mucosa) of cattle].
Kolb E; Schineff C
Arch Exp Veterinarmed; 1975 Dec; 29(6):839-55. PubMed ID: 132147
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of digitonin on some enzyme activities of the sodium pump.
Winter CG
Biochim Biophys Acta; 1972 Apr; 266(1):135-43. PubMed ID: 4339318
[No Abstract] [Full Text] [Related]
18. Kinetics of oligomycin inhibition of sodium- and potassium-activated adenosine triphosphatase from beef brain.
Inturrisi CE; Titus E
Mol Pharmacol; 1968 Nov; 4(6):591-9. PubMed ID: 4235717
[No Abstract] [Full Text] [Related]
19. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
Tobin T; Akera T; Ku D; Lu MC
Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
[No Abstract] [Full Text] [Related]
20. The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain.
Akera T; Brody TM
Mol Pharmacol; 1969 Nov; 5(6):605-14. PubMed ID: 4244695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
